LONDON BROKER RATINGS: Citi and Jefferies say buy Astra after tumble
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 161.80p on 20-07-2026 at 18:25:11 |
|---|---|
| Change | 0.80p 0.5% |
| Buy | 162.00p |
| Sell | 161.80p |
| Last Trade: | Sell 2,241.00 at 161.80p |
| Day's Volume: | 930,635 |
| Last Close: | 161.80p |
| Open: | 159.40p |
| ISIN: | GB0002418548 |
| Day's Range | 159.40p - 162.40p |
| 52wk Range: | 136.00p - 179.60p |
| Market Capitalisation: | £921.80m |
| VWAP: | 161.44141p |
| Shares in Issue: | 569.71m |
Elementis (ELM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 2,241 | 161.80p | Automatic Execution |
16:36:00 - 20-Jul-26 |
| Buy* | 7,759 | 161.80p | Automatic Execution |
16:35:27 - 20-Jul-26 |
| Buy* | 169,881 | 161.80p | Suspected BUY Trade |
16:35:21 - 20-Jul-26 |
| Buy* | 166 | 162.00p | Automatic Execution |
16:29:53 - 20-Jul-26 |
| Buy* | 45 | 162.00p | SI Trade |
16:29:42 - 20-Jul-26 |
| Buy* | 39 | 162.00p | SI Trade |
16:29:40 - 20-Jul-26 |
| Buy* | 4 | 162.00p | SI Trade |
16:28:34 - 20-Jul-26 |
| Buy* | 1 | 162.00p | SI Trade |
16:27:12 - 20-Jul-26 |
| Sell* | 1,402 | 161.80p | Automatic Execution |
16:25:19 - 20-Jul-26 |
| Buy* | 634 | 162.00p | Automatic Execution |
16:25:10 - 20-Jul-26 |
Elementis (ELM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Jul 2026 5:45 pm | RNS | Transaction in Own Shares |
| 6th Jul 2026 5:24 pm | RNS | Transaction in Own Shares |
| 1st Jul 2026 6:26 pm | RNS | Total Voting Rights |
| 29th Jun 2026 6:11 pm | RNS | Transaction in Own Shares |
| 22nd Jun 2026 2:42 pm | RNS | Transaction in Own Shares |
| 22nd Jun 2026 2:30 pm | RNS | Transaction in Own Shares |
| 15th Jun 2026 12:42 pm | RNS | Transaction in Own Shares |
| 8th Jun 2026 5:14 pm | RNS | Transaction in Own Shares |
| 3rd Jun 2026 7:00 am | RNS | Commencement of share buyback programme |
| 2nd Jun 2026 7:00 am | RNS | Sale of Pharma business & intended buyback launch |